X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs NOVARTIS - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS NOVARTIS J.B.CHEMICALS/
NOVARTIS
 
P/E (TTM) x 20.3 406.3 5.0% View Chart
P/BV x 2.1 32.5 6.4% View Chart
Dividend Yield % 0.6 1.4 40.2%  

Financials

 J.B.CHEMICALS   NOVARTIS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
NOVARTIS
Mar-18
J.B.CHEMICALS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs363758 47.9%   
Low Rs255579 44.0%   
Sales per share (Unadj.) Rs169.1228.4 74.1%  
Earnings per share (Unadj.) Rs16.631.7 52.3%  
Cash flow per share (Unadj.) Rs23.432.8 71.5%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.61.5 43.3%  
Book value per share (Unadj.) Rs172.5297.1 58.1%  
Shares outstanding (eoy) m83.5724.69 338.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.9 62.4%   
Avg P/E ratio x18.621.1 88.4%  
P/CF ratio (eoy) x13.220.4 64.7%  
Price / Book Value ratio x1.82.2 79.6%  
Dividend payout %12.031.5 38.2%   
Avg Mkt Cap Rs m25,82716,505 156.5%   
No. of employees `0003.80.7 564.7%   
Total wages/salary Rs m2,5111,445 173.7%   
Avg. sales/employee Rs Th3,747.48,441.3 44.4%   
Avg. wages/employee Rs Th665.72,163.6 30.8%   
Avg. net profit/employee Rs Th367.81,173.1 31.4%   
INCOME DATA
Net Sales Rs m14,1355,639 250.7%  
Other income Rs m3661,718 21.3%   
Total revenues Rs m14,5017,357 197.1%   
Gross profit Rs m2,178-63 -3,485.3%  
Depreciation Rs m57025 2,251.8%   
Interest Rs m3555 63.1%   
Profit before tax Rs m1,9401,575 123.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m552792 69.8%   
Profit after tax Rs m1,387784 177.0%  
Gross profit margin %15.4-1.1 -1,390.4%  
Effective tax rate %28.550.3 56.7%   
Net profit margin %9.813.9 70.6%  
BALANCE SHEET DATA
Current assets Rs m10,4709,522 110.0%   
Current liabilities Rs m2,7493,296 83.4%   
Net working cap to sales %54.6110.4 49.5%  
Current ratio x3.82.9 131.8%  
Inventory Days Days5537 150.7%  
Debtors Days Days7828 273.2%  
Net fixed assets Rs m5,81146 12,632.9%   
Share capital Rs m167123 135.4%   
"Free" reserves Rs m14,2487,213 197.5%   
Net worth Rs m14,4167,336 196.5%   
Long term debt Rs m00-   
Total assets Rs m17,64911,105 158.9%  
Interest coverage x56.629.5 191.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 157.7%   
Return on assets %8.17.6 106.7%  
Return on equity %9.610.7 90.1%  
Return on capital %13.722.2 61.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16461 10,171.4%   
Fx outflow Rs m1,3343,630 36.8%   
Net fx Rs m4,829-3,570 -135.3%   
CASH FLOW
From Operations Rs m1,2311,610 76.4%  
From Investments Rs m-208687 -30.3%  
From Financial Activity Rs m-595-2,677 22.2%  
Net Cashflow Rs m427-380 -112.5%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 3.4 2.0 169.5%  
FIIs % 3.9 1.6 243.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 21.5 172.1%  
Shareholders   30,437 41,647 73.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 324 Points Lower; Metal and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY18); Net Profit Up 809.6% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, NOVARTIS has posted a net profit of Rs 265 m (up 809.6% YoY). Sales on the other hand came in at Rs 1 bn (down 13.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Apr 25, 2019 03:37 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - AJANTA PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS